BH

Babubhai Hargovandas Patel

Active Director Director DIN 03256465
DIN 03256465 First appointment Sep 2010 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2010
Shareholding value β€’β€’β€’β€’ Premium profile

About Babubhai Hargovandas Patel

Data last updated:

Babubhai Hargovandas Patel is a Director at Umbilical Pharmaceuticals Private Limited (since 2010). The company operates in Pharma.

DIN 03256465
Primary Designation Director
Industry Pharma
First Appointment 22 Sep 2010
Oldest Company Age 17 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director22 Sep 20102009Active

Board colleagues of Babubhai Hargovandas Patel

Directorship timeline

Open interactive timeline →
Umbilical Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Babubhai Hargovandas Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Babubhai Hargovandas Patel

Babubhai Hargovandas Patel currently holds 1 directorship: Umbilical Pharmaceuticals Private Limited (Director, since 22 Sep 2010).

Babubhai Hargovandas Patel was first appointed on 22 Sep 2010 as Director at Umbilical Pharmaceuticals Private Limited.

The current boards of Babubhai Hargovandas Patel's companies include Manish Babubhai Patel (Umbilical Pharmaceuticals Private Limited), Mayur Babubhai Patel (Umbilical Pharmaceuticals Private Limited), Vishnubhai Manibhai Patel (Umbilical Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available